The Chinese government defended widespread immunizations against COVID-19 outside of clinical trials in the country. The vaccinations were warranted, as there were no documented side effects from the experimental vaccines, and imported COVID-19 cases proved to be a serious risk to the country. Chinese National Health Commission director for coronavirus vaccine development Zheng Zhongwei said Oct. 20 that China … Continue reading Who needs SCIENCE? China justifies widespread COVID-19 immunizations without bothering with clinical trials
China’s coronavirus vaccine production may be unable to fulfill commitments to other countries
China has promised to fast-track the development of an effective coronavirus vaccine before the year ends and share this vaccine with other countries as part of its contribution to the fight against COVID-19. However, some have questioned China’s capability to produce sufficient doses. They also raised concerns with the country’s deals with individual nations. Chinese leader Xi … Continue reading China’s coronavirus vaccine production may be unable to fulfill commitments to other countries
AstraZeneca’s no-profit pledge for coronavirus vaccines may end in 2021
A memorandum of understanding between British pharmaceutical company AstraZeneca and Brazilian public health research institution Fiocruz obtained by The Financial Times stated the drugmaker has the right to declare the pandemic’s end by July 2021. Under the document’s terms, AstraZeneca will also be providing doses of its coronavirus vaccine – developed in tandem with the University of Oxford – on a cost … Continue reading AstraZeneca’s no-profit pledge for coronavirus vaccines may end in 2021
